Return to search results
Famotidine
Famotidine is a prescription oral suspension (40 mg/5 mL) that reduces stomach acid production. It's used to treat conditions like ulcers, heartburn, and acid reflux by blocking histamine H2 receptors. Manufactured by Lupin Pharmaceuticals, Inc. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Famotidine is a prescription oral suspension (40 mg/5 mL) that reduces stomach acid production. It's used to treat conditions like ulcers, heartburn, and acid reflux by blocking histamine H2 receptors. Manufactured by Lupin Pharmaceuticals, Inc. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Famotidine",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Famotidine — ANDA 217400 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217400"
}
]
|
| identifier | ANDA217400 |
| issued | 2016-09-16 |
| keyword |
[
"drug-manufacturers",
"drug-safety",
"fda",
"medications",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Famotidine |
